Mounjaro Timeline: When Do You See Results?

Mounjaro does not produce a change on the scale in the first week. What people usually notice first is reduced appetite within a few days of injecting. Weight changes gradually, over weeks to months — and the main trial used a 72-week follow-up frame.

When does Mounjaro start working?

The fastest effect is on appetite, not on weight. Tirzepatide acts on the GIP and GLP-1 receptors, which signal fullness and slow gastric emptying. Many people therefore notice within the first few days that they eat less, feel full sooner, and think about food less during the day.

Weight follows as a consequence of sustained lower energy intake, so it takes weeks to accumulate into a visible difference on the scale. Weighing daily during the first week and concluding it is not working is a common misreading.

The point worth emphasising is that the starting dose of this medication is not designed primarily to reduce weight. It is designed to let the digestive system adapt gradually to slower gastric emptying. The goal of the first month is tolerability, not a weight figure.

A rough timeline

The table below is a general frame for expectations, not a treatment schedule. The actual plan is set by your doctor after assessment.

Dose increases are generally made in steps roughly every 4 weeks, and only once the current dose is well tolerated. The essential point is that stepping up is a clinical decision based on each person’s response and side effects — not an automatic schedule. Escalating on your own only raises the chance of gastrointestinal symptoms severe enough to force stopping.

At Onnyx Clinic the pens stocked are 2.5 mg, the starting dose, and 5 mg, the step-up dose based on response, with the doctor deciding when to adjust.

What the trial says about results and timeframe

The figures generally cited come from SURMOUNT-1, published in the New England Journal of Medicine, which followed 2,539 adults with obesity or overweight and without diabetes for 72 weeks.

Reported average weight loss was roughly 16.0-22.5% depending on the dose studied, against 2.4% on placebo, with roughly 89-96% of participants on the medication losing at least 5% of body weight.

What these figures say about time is that the frame is 72 weeks, not 4 or 8. The reported results reflect sustained long-term use alongside behaviour change. Expecting results of that magnitude within one or two months is not consistent with the data. Results vary between individuals and there is no guarantee of any particular figure.

Why do some people respond more slowly?

Differences between individuals come from several factors together:

• The current dose — during the early period at the starting dose, the effect on weight is usually smaller than after stepping up
• Eating patterns not yet adjusted — the medication reduces appetite, but if the food eaten remains very energy-dense the net effect may be modest
• Muscle mass and physical activity, which determine resting energy use
• Sleep and stress, both linked to hunger hormones
• Other medications, some of which are associated with weight gain
• Other health conditions, such as untreated hypothyroidism

If you have used the medication consistently for several months with dose adjustments as planned and still see no change, go back to your doctor to review both the medication plan and the factors above, rather than increasing the dose yourself.

How long should treatment continue?

There is no single answer. The working frame treats obesity as a chronic condition requiring ongoing care, similar to high blood pressure. Duration therefore depends on the weight target, weight-related complications, response, side effects, and the plan for after stopping.

Worth discussing with your doctor early is what happens after stopping, because trial data show weight tends to return partially once medication is withdrawn.

Making the treatment period count

The period when medication makes hunger easier to manage is the period when behaviour is easiest to change. Using it well is what makes results stay with you afterwards.

1. Eat enough protein at every meal to preserve muscle while total intake falls
2. Do resistance training at least twice a week
3. Record weight weekly rather than daily, to read the trend instead of daily fluctuation
4. Keep follow-up appointments so dose adjustments rest on real data
5. Report side effects honestly — a plan adjusted in time usually beats enduring symptoms and quitting midway

If you are considering starting, or already using it and want to check whether your timeline is on track, consult a doctor at Onnyx Clinic for individual assessment. Mounjaro pens start at 2,499 THB. Ask via LINE: @onnyxclinic

References

• Tirzepatide Once Weekly for the Treatment of Obesity — SURMOUNT-1 (NEJM)
• Lilly: SURMOUNT-1 results published in NEJM
• How should Mounjaro (tirzepatide) doses be increased in adults? (Lilly Medical)
• Gastrointestinal tolerability of tirzepatide in SURMOUNT-1 to -4 (Diabetes, Obesity and Metabolism)
• Thai Food and Drug Administration